Oxford BioDynamics (OXBOF) Ratios

9 Followers

Oxford BioDynamics Ratios

OXBOF's free cash flow for Q2 2026 was £-0.35. For the 2026 fiscal year, OXBOF's free cash flow was decreased by £ and operating cash flow was £-6.86. See a summary of the company’s cash flow.

Ratios	TTM	Sep 25	Sep 24	Sep 23	Sep 22
Liquidity Ratios
Current Ratio	2.01	0.88	1.97	1.79	0.95
Quick Ratio	1.89	0.80	1.84	1.72	0.83
Cash Ratio	1.32	0.53	0.71	1.31	0.33
Solvency Ratio	-1.49	-1.43	-1.30	-0.94	-0.63
Operating Cash Flow Ratio	-3.83	-2.96	-3.97	-2.07	-1.78
Short-Term Operating Cash Flow Coverage	-8.06	0.00	-9.72	-10.14	-7.03
Net Current Asset Value	£ -2.03M	£ -4.69M	£ -2.70M	£ -2.90M	£ -5.99M
Leverage Ratios
Debt-to-Assets Ratio	0.47	0.63	0.47	0.40	0.54
Debt-to-Equity Ratio	1.32	4.58	1.32	1.06	2.37
Debt-to-Capital Ratio	0.57	0.82	0.57	0.52	0.70
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	2.80	7.25	2.78	2.66	4.38
Debt Service Coverage Ratio	-7.24	-22.59	-7.77	-8.98	-5.69
Interest Coverage Ratio	-32.55	-25.27	-57.31	-51.77	-44.11
Debt to Market Cap	0.37	0.00	0.13	0.01	0.06
Interest Debt Per Share	<0.01	<0.01	0.02	0.05	0.06
Net Debt to EBITDA	-0.20	-0.38	-0.38	-0.12	-0.84
Profitability Margins
Gross Profit Margin	-277.32%	-561.55%	45.44%	52.16%	75.32%
EBIT Margin	-840.17%	-1004.57%	-1844.50%	-2195.69%	-4787.01%
EBITDA Margin	-743.77%	-895.07%	-1613.99%	-1929.61%	-3999.35%
Operating Profit Margin	-792.72%	-973.79%	-2027.36%	-2161.96%	-5585.06%
Pretax Profit Margin	-846.03%	-1043.11%	-1879.87%	-2237.45%	-4913.64%
Net Profit Margin	-825.61%	-1018.54%	-1818.71%	-2122.75%	-4357.14%
Continuous Operations Profit Margin	-825.61%	-1018.54%	-1818.71%	-2122.75%	-4357.14%
Net Income Per EBT	97.59%	97.64%	96.75%	94.87%	88.67%
EBT Per EBIT	106.72%	107.12%	92.73%	103.49%	87.98%
Return on Assets (ROA)	-108.54%	-137.93%	-95.53%	-67.13%	-59.15%
Return on Equity (ROE)	-451.74%	-999.37%	-265.42%	-178.79%	-259.27%
Return on Capital Employed (ROCE)	-131.72%	-194.58%	-135.09%	-90.93%	-101.99%
Return on Invested Capital (ROIC)	-114.20%	-153.84%	-107.20%	-76.01%	-77.00%
Return on Tangible Assets	-123.20%	-159.79%	-107.53%	-76.16%	-68.87%
Earnings Yield	-225.55%	-169.28%	-140.47%	-19.84%	-58.52%
Efficiency Ratios
Receivables Turnover	1.12	1.58	0.46	0.31	0.11
Payables Turnover	4.53	12.22	0.36	0.50	0.04
Inventory Turnover	19.78	37.15	1.08	0.89	0.11
Fixed Asset Turnover	0.28	0.23	0.11	0.07	0.02
Asset Turnover	0.13	0.14	0.05	0.03	0.01
Working Capital Turnover Ratio	1.51	1.01	0.23	0.34	0.07
Cash Conversion Cycle	263.82	211.28	130.07	860.24	-1.61K
Days of Sales Outstanding	325.90	231.33	794.85	1.18K	3.39K
Days of Inventory Outstanding	18.46	9.83	337.65	409.88	3.24K
Days of Payables Outstanding	80.54	29.88	1.00K	725.51	8.23K
Operating Cycle	344.36	241.16	1.13K	1.59K	6.62K
Cash Flow Ratios
Operating Cash Flow Per Share	>-0.01	>-0.01	-0.04	-0.06	-0.05
Free Cash Flow Per Share	>-0.01	>-0.01	-0.04	-0.06	-0.06
CapEx Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.06	1.09	1.17
Dividend Paid and CapEx Coverage Ratio	-303.13	-453.47	-17.10	-11.58	-5.75
Capital Expenditure Coverage Ratio	-303.13	-453.47	-17.10	-11.58	-5.75
Operating Cash Flow Coverage Ratio	-1.70	-1.51	-1.77	-1.29	-0.84
Operating Cash Flow to Sales Ratio	-6.09	-7.04	-15.99	-16.26	-33.62
Free Cash Flow Yield	-297.91%	-117.26%	-130.76%	-16.51%	-53.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-0.29	-0.59	-0.71	-5.04	-1.71
Price-to-Sales (P/S) Ratio	2.05	6.02	12.95	107.00	74.45
Price-to-Book (P/B) Ratio	1.35	5.90	1.89	9.01	4.43
Price-to-Free Cash Flow (P/FCF) Ratio	-0.34	-0.85	-0.76	-6.06	-1.89
Price-to-Operating Cash Flow Ratio	-0.60	-0.85	-0.81	-6.58	-2.21
Price-to-Earnings Growth (PEG) Ratio	>-0.01	<0.01	0.02	-0.56	0.25
Price-to-Fair Value	1.35	5.90	1.89	9.01	4.43
Enterprise Value Multiple	-0.47	-1.05	-1.18	-5.67	-2.70
Enterprise Value	4.22M	10.31M	12.15M	55.76M	16.63M
EV to EBITDA	-0.47	-1.05	-1.18	-5.67	-2.70
EV to Sales	3.53	9.41	19.10	109.33	107.97
EV to Free Cash Flow	-0.58	-1.33	-1.13	-6.19	-2.74
EV to Operating Cash Flow	-0.58	-1.34	-1.19	-6.72	-3.21
Tangible Book Value Per Share	<0.01	<0.01	0.01	0.03	<0.01
Shareholders’ Equity Per Share	<0.01	<0.01	0.02	0.04	0.03
Tax and Other Ratios
Effective Tax Rate	0.02	0.02	0.03	0.05	0.11
Revenue Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Net Income Per Share	>-0.01	>-0.01	-0.05	-0.07	-0.07
Tax Burden	0.98	0.98	0.97	0.95	0.89
Interest Burden	1.01	1.04	1.02	1.02	1.03
Research & Development to Revenue	0.35	0.56	1.27	1.49	3.42
SG&A to Revenue	4.81	3.56	7.04	6.69	15.92
Stock-Based Compensation to Revenue	0.00	0.00	0.81	0.65	2.56
Income Quality	0.74	0.69	0.85	0.77	0.68

Currency in GBP